Is RECEF or JEPQ a better dividend investment in 2026?

RECEF currently yields 909.09% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: RECEF offers higher current income.

What is the dividend yield difference between RECEF and JEPQ?

RECEF has a forward dividend yield of 909.09% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 897.99 percentage points.

Home › Compare › RECEF vs JEPQ

RECEF vs JEPQ: Dividend Comparison 2026

RECEF yields 909.09% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RECEF wins by $8252648.17M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RECEF

● Live price

909.09%

Share price

$0.22

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8252648.21M

Annual income

$6,784,560,004,057.53

Full RECEF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — RECEF vs JEPQ

📍 RECEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RECEF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RECEF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RECEF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RECEF

Annual income on $10K today (after 15% tax)

$77,272.73/yr

After 10yr DRIP, annual income (after tax)

$5,766,876,003,448.90/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, RECEF beats the other by $5,766,876,001,619.20/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RECEF + JEPQ for your $10,000?

RECEF: 50%JEPQ: 50%

100% JEPQ50/50100% RECEF

Portfolio after 10yr

$4126324.13M

Annual income

$3,392,280,003,105.06/yr

Blended yield

82.21%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RECEF buys

JEPQ buys

No recent congressional trades found for RECEF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRECEFJEPQ

Forward yield	909.09% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$8252648.21M ✓	$44.8K
Annual income after 10y	$6,784,560,004,057.53 ✓	$2,152.59
Total dividends collected	$8138900.96M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: RECEF vs JEPQ ($10,000, DRIP)

Year	RECEF Portfolio	RECEF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$101,609	$90,909.09	$11,930	$1,110.39	+$89.7K → RECEF
2	$972,011	$863,288.79	$14,133	$1,224.34	+$957.9K → RECEF
3	$8,758,157	$7,718,105.75	$16,632	$1,340.46	+$8.74M → RECEF
4	$74,364,546	$64,993,317.91	$19,454	$1,457.97	+$74.35M → RECEF
5	$595,318,755	$515,748,691.06	$22,626	$1,576.08	+$595.30M → RECEF
6	$4,495,664,203	$3,858,673,134.79	$26,175	$1,694.09	+$4495.64M → RECEF
7	$32,043,550,537	$27,233,189,840.42	$30,133	$1,811.32	+$32043.52M → RECEF
8	$215,696,715,677	$181,410,116,602.38	$34,531	$1,927.17	+$215696.68M → RECEF
9	$1,372,045,052,584	$1,141,249,566,809.58	$39,403	$2,041.08	+$1372045.01M → RECEF
10	$8,252,648,210,323	$6,784,560,004,057.53	$44,787	$2,152.59	+$8252648.17M → RECEF

RECEF vs JEPQ: Complete Analysis 2026

RECEF — Stock

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic antiinfectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

Full RECEF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this RECEF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RECEF vs SCHD RECEF vs JEPI RECEF vs O RECEF vs KO RECEF vs MAIN RECEF vs XYLD RECEF vs QYLD RECEF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.